Latest news
FDA approves Orzeyful, first drug to treat all symptoms of narcolepsy type 1 - Managed Healthcare ExecutiveManaged Healthcare Executive · Fri, 07 Aug 2026 20:06:51 GMTFDA approves first-in-class drug to treat narcolepsy - Drug Discovery NewsDrug Discovery News · Fri, 07 Aug 2026 19:48:16 GMTFDA approves Takeda’s first-in-class narcolepsy drug - EMJEMJ · Fri, 07 Aug 2026 15:12:52 GMTFDA Approves First Narcolepsy Drug That Targets the Brain Signal Loss Behind the Disorder - Medical DailyMedical Daily · Fri, 07 Aug 2026 10:30:02 GMTTakeda nets first-in-class advantage on narcolepsy drug’s FDA go-ahead - Pharmaceutical TechnologyPharmaceutical Technology · Fri, 07 Aug 2026 09:53:37 GMTFDA Approves Oveporexton, First Orexin Receptor Agonist for Narcolepsy Type 1 - Patient Care OnlinePatient Care Online · Fri, 07 Aug 2026 06:16:23 GMTFDA Approves First Orexin-Targeting Therapy for Narcolepsy Type 1 - Medical DialoguesMedical Dialogues · Fri, 07 Aug 2026 02:30:09 GMTFDA approves first drug for full range of narcolepsy symptoms - Medical XpressMedical Xpress · Thu, 06 Aug 2026 22:00:03 GMT